Stem Cells and Cancer Stem Cells.Vol.8

Preface. I. Stem cell culture.-1 Stem cell culture: optimizing amidst the complexity.-2 Development of defined culture conditions for expansion of human mesenchymal stromal cells for clinical applications.-3 Retention of stem cell properties post-expansion in myosphere culture.II. Bone marrow stem cells.-4Role of reactive oxygen species formation form oxidized low density lipoprotein in bone marrow stem cells.-5 The role of bone marrow-derived progenitor cells in tumor growth and angiogenesis.-6 Myelodysplastic stem cells: gene expression profiling.III. Mesenchymal stem cells.-7Human mesenchymal stem cell transdifferentiation to neural cells: role of tumor necrosis factor alpha.-8 Role of mesenchymal stem cells (msc) in hiv-1 associated bone and lipid toxicities.-9 Mesenchymal stem cell therapy: immunomodulation and homing mechanisms.-10 Mesenchymal stem cells: the role of endothelial cells and the vasculature.-11 Use of cancer/testis antigens in immunotherapy: potential effect on mesenchymal stem cells.IV. Reprogramming and differentiation of stem cells.-12 Regulation of self-renewal and pluripotency of embryonic stem cells: role of natriuretic peptide receptor.-13 Reprogramming and pluripotency of epiblast stem cells.-14Epigenetic modifiers and stem cell differentiation.-15 Enrichment and selection of stem cell-derived tissue-specific precursors.-16 Differentiation of pluripotent stem cells into steroidogenic cells: role of sf-1 regulator.-17 Human embryonic stem cell differentiation: role of glycosphingolipid structure.-18 Differentiation of human embryonic stem cells into pancreatic endocrine cells.-19 ransformation of vascular endothelial cells into multipotent stem-like cells: role of the activin-like kinase 2 receptor.V. Treatment.-20 Colon cancer stem cells: a therapeutic target.-21 Treatment of damaged brain following a stroke: new strategies.-22 Parthenogenetic activation-induced pluripotent stem cells and potential applications.-23 Neuroprotection